AEterna Zentaris: Top 10 Undervalued Growth Stocks on TSX (AEZS)
AEterna Zentaris is now ranked among the top 10 undervalued small cap growth stocks on the Toronto Stock Exchange (TSX).
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
- Small, micro and nano group market capitalization (<10B)
Stocks in this category that have grown their revenue significantly in their latest quarterly report. They are held primarily for capital appreciation but do present downside risk. Growth stocks are always of interest to investors as they present upside opportunity. Stocks that are both growing their quarterly revenue and showing as undervalued are of special interest as these two factors are important when looking for prospects.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| FAF | Fire & Flower Holdings | 0.29 | 0.42 | 0.13 (43.7%) | 13.2 | 0.0 | 0.0 | |
| PMN | ProMIS Neurosciences | 6.24 | 6.47 | 0.23 (3.7%) | 10525 | 53.5 | 0.0 | 0.0 |
| AAB | Aberdeen International | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AAUC | Allied Gold | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AAV | Advantage Energy | - | - | - (0.0%) | 0.0 | 0.0 | 20.8 | |
| AC | Air Canada | - | - | - (0.0%) | 0.0 | 0.0 | 2.8 | |
| ACB | Aurora Cannabis | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| ACQ | AutoCanada | - | - | - (0.0%) | 0.0 | 0.0 | 11.8 | |
| ACX | ACT Energy Technologies | - | - | - (0.0%) | 0.0 | 0.0 | 12.0 | |
| ADCO | Adcore | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AEG | Aegis Brands | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AEZS | AEterna Zentaris | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AGRI-U | Agrinam Acq | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AIDX | Healwell AI | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AII | Almonty Indus | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AIM | Aimia | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AKT-A | Akita Drilling | - | - | - (0.0%) | 0.0 | 0.0 | 5.0 | |
| AKT-B | Akita Drilling | - | - | - (0.0%) | 0.0 | 0.0 | 12.7 | |
| AKU | Akumin | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| ALYA | Alithya Group | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AMC | Arizona Metals | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AMM | Almaden Minerals | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| ANRG | Anaergia | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AOT | Ascot Resources | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| APLI | Appili Therapeutics | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 |
All data provided as of July 27, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Companies included above have not paid a dividend in the last 12-months.
AEterna Zentaris
AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of significant unmet medical need. One of Aeterna's lead products is macimorelin (Macrilen; Ghryvelin), the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD).
AEterna Zentaris is listed under AEZS on the Toronto Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
